Leptin Levels and Overweight in Childhood Leukemia Survivors
Author Information
Author(s): Skoczen Szymon, Tomasik Przemyslaw J, Bik-Multanowski Miroslaw, Surmiak Marcin, Balwierz Walentyna, Pietrzyk Jacek J, Sztefko Krystyna, Gozdzik Jolanta, Galicka-Latała Danuta, Strojny Wojciech
Primary Institution: Jagiellonian University Medical College
Hypothesis
The study aims to assess leptin levels and gene polymorphisms in survivors of pediatric acute lymphoblastic leukemia and their relationship with overweight status.
Conclusion
Leptin and leptin receptor levels may serve as useful markers for high risk of becoming overweight in ALL survivors, particularly in females treated with cranial radiotherapy.
Supporting Evidence
- The prevalence of overweight in the study cohort was 31%, higher than the general European population rate of 20%.
- Leptin levels were significantly higher in overweight patients compared to non-overweight patients.
- Cranial radiotherapy was associated with increased leptin levels in both the entire group and female patients.
Takeaway
This study found that many kids who survived leukemia are overweight, and measuring a hormone called leptin can help understand their risk of gaining more weight.
Methodology
The study analyzed plasma leptin levels and genetic polymorphisms in 82 survivors of childhood ALL, assessing the impact of treatment regimens and cranial radiotherapy.
Potential Biases
Potential biases may arise from the retrospective nature of the study and reliance on self-reported data.
Limitations
The small sample size may limit the generalizability of the findings.
Participant Demographics
The cohort consisted of 82 patients, 55% male, with a median age of 13.2 years.
Statistical Information
P-Value
p < 0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website